Investigation of the bioequivalence of montelukast chewable tablets after a single oral administration using a validated LC-MS/MS method

BACKGROUND: Montelukast (MT) is a leukotriene D4 antagonist. It is an effective and safe medicine for the prophylaxis and treatment of chronic asthma. It is also used to prevent acute exercise-induced bronchoconstriction and as a symptomatic relief of seasonal allergic rhinitis and perennial allergi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zaid, Abdel Naser, Abualhasan, Murad N, Watson, David G, Mousa, Ayman, Ghazal, Nadia, Bustami, Rana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4590312/
https://www.ncbi.nlm.nih.gov/pubmed/26451086
http://dx.doi.org/10.2147/DDDT.S87938

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4590312/
https://www.ncbi.nlm.nih.gov/pubmed/26451086
http://dx.doi.org/10.2147/DDDT.S87938

Ejemplares similares